![](/img/cover-not-exists.png)
A crossing in therapy for hepatitis C virus genotype 2 or 3: Increasing ribavirin dose with shortened duration or reducing ribavirin dose with standard duration
Chung-Feng Huang, Chia-Yen Dai, Jee-Fu Huang, Wan-Long Chuang, Ming-Lung YuVolume:
49
Year:
2009
Language:
english
Pages:
2
DOI:
10.1002/hep.22863
File:
PDF, 56 KB
english, 2009